Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Valproate is a mood stabilizer for bipolar disorder but has side effects and risks, especially during pregnancy.

Women with PCOS often experience mental health issues like depression and anxiety.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Hirsutism causes significant psychological distress in women.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Differentiating PCOS from NCAH helps improve diagnosis and treatment.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

HAIR may cause fetal loss by triggering different cell death processes in the uterus and placenta.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.